IRMD vs LIVN
IRMD: A specialist medical device company providing the only known MRI-compatible non-magnetic IV infusion pumps and advanced patient vital signs monitoring systems for the magnetic resonance imaging environment. LIVN: LivaNova is a medical technology company specializing in innovative cardiovascular and neuromodulation therapies to improve patient lives.
Side-by-side fundamentals
| Metric | IRMD | LIVN | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $95.08 | $81.05 | |
| Market cap as of 2026-07-31 | $1.2B | $4.4B | |
| P/E as of 2026-07-31 | 51.03 | 41.64 | LIVN lower |
| PEG as of 2026-07-31 | 2.74 | 3.92 | IRMD lower |
| Net margin as of 2026-07-31 | +27.4% | +7.5% | IRMD higher |
| Gross margin as of 2026-07-31 | +76.8% | +67.5% | IRMD higher |
| Operating margin as of 2026-07-31 | +32.4% | +13.1% | IRMD higher |
| ROE as of 2026-07-31 | +24.5% | +9.1% | IRMD higher |
| ROA as of 2026-07-31 | +21.3% | +4.2% | IRMD higher |
| Debt / equity as of 2026-07-31 | 0.00 | 0.24 | IRMD lower |
| Revenue growth (YoY) as of 2026-07-31 | +14.8% | +12.4% | IRMD higher |
| Revenue CAGR (3y) SEC XBRL | +16.3% | +10.8% | IRMD higher |
| Dividend yield as of 2026-07-31 | +0.8% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-07-31 | 0.92 | 0.92 | |
| 1-year return as of 2026-07-27 close | +68.8% | +84.2% | LIVN higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.